- Home
- CRBU vs APUR Comparison
CRBU vs APUR Comparison
Compare CRBU & APUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBU | APUR |
|---|---|---|
| Founded | 2011 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.3M | 146.9M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CRBU | APUR |
|---|---|---|
| Price | $1.24 | $10.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.86 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 364.8K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $128.04 | N/A |
| Revenue Next Year | $17.09 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $9.90 |
| 52 Week High | $3.53 | $10.04 |
Technical Indicators
Market Signals| Indicator | CRBU | APUR |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 69.55 |
| Support Level | N/A | $9.90 |
| Resistance Level | $1.74 | N/A |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 32.14 | 100.00 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
About APUR Aperture AC Class A Ordinary Shares
Aperture AC is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.